Immunosuppression with melengestrol.
D000287:Administration, Topical; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D004285:Dogs; D004306:Dose-Response Relationship, Immunologic; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy / Q000473:pathology; D005938:Glucocorticoids; D006085:Graft Survival / Q000187:drug effects; D016027:Heart Transplantation; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis; D007166:Immunosuppressive Agents; D016030:Kidney Transplantation; D008552:Melengestrol Acetate / Q000494:pharmacology*; D011245:Pregnadienes / Q000494:pharmacology*; D011372:Progestins / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D016038:Skin Transplantation; D014184:Transplantation, Homologous
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D011245:Pregnadienes; D011372:Progestins; D008552:Melengestrol Acetate